Key Takeaways
- • William Blair has acquired Armentum Partners, a boutique debt and alternative capital advisory firm serving venture-backed businesses, public companies, and academic institutions, marking the firm's second investment banking acquisition of the year.
- • Armentum brings enterprise value lending, asset-based lending, and royalty monetization capabilities to William Blair's capital markets and debt advisory platform, with a focus on healthcare and technology.
- • All Armentum professionals are expected to join William Blair, which will open a Menlo Park office to establish a Silicon Valley presence.
- • Armentum has raised over $22 billion across more than 390 transactions since its inception, according to its company description.
- • The deal comes as venture-backed and public companies increasingly turn to non-dilutive private credit and direct lending to fund growth.
Summary
William Blair announced that it has acquired Armentum Partners, a boutique debt and alternative capital solutions advisory firm serving venture-backed businesses, public companies, and academic institutions. The transaction is the second investment banking acquisition completed by William Blair this year and reflects continued investment in healthcare, technology, and the venture capital ecosystem, according to the firm.
Armentum advises high-growth companies on bespoke capital solutions, drawing on long-standing relationships with venture capital firms, public companies, and growth-focused and enterprise-value lenders. The firm also advises academic institutions and life sciences companies on royalty monetization, helping them capitalize on intellectual property. Its professionals are based in Boston, Chicago, Menlo Park, New York, Philadelphia, and San Francisco and serve clients in the U.S. and Europe. According to Armentum's company description, the firm is led by senior bankers with more than 200 years of combined experience and has raised over $22 billion across 390-plus transactions since its founding in Silicon Valley.
As part of the deal, William Blair will open an office in Menlo Park. All Armentum professionals are expected to join the firm, and Armentum will continue operating under its existing name for a period after closing. Clearsight Advisors, Inc. served as financial advisor to Armentum. The transaction terms were not disclosed in the materials reviewed.
Matt Zimmer, global head of investment banking at William Blair, said the acquisition extends the firm's offering across the venture capital, public company, and collegiate communities. Steve Maletzky, head of capital markets, described enterprise value lending as a specialized discipline that finances companies against the value of their assets, often before traditional cash flows exist. Armentum's Hutch Corbett said the combination gives clients access to a broader set of services, including public and private equity capital raising, M&A advisory, secondary advisory, primary fund raising, and equity research.
The acquisition follows rapid growth in private credit and direct lending, as venture-backed and public companies seek flexible, non-dilutive capital for growth in sectors including healthcare innovation, artificial intelligence, software, fintech, and industrial technology. Demand has been especially strong among later-stage technology and biopharmaceutical companies financing clinical trials and commercialization. William Blair has recently expanded its life sciences team with the addition of Michael Allwin as head of Biopharma investment banking, Emanuela Branchetti as managing director of scientific affairs, and Alethia Young in equity research.
Armentum advises high-growth companies on bespoke capital solutions, drawing on long-standing relationships with venture capital firms, public companies, and growth-focused and enterprise-value lenders. The firm also advises academic institutions and life sciences companies on royalty monetization, helping them capitalize on intellectual property. Its professionals are based in Boston, Chicago, Menlo Park, New York, Philadelphia, and San Francisco and serve clients in the U.S. and Europe. According to Armentum's company description, the firm is led by senior bankers with more than 200 years of combined experience and has raised over $22 billion across 390-plus transactions since its founding in Silicon Valley.
As part of the deal, William Blair will open an office in Menlo Park. All Armentum professionals are expected to join the firm, and Armentum will continue operating under its existing name for a period after closing. Clearsight Advisors, Inc. served as financial advisor to Armentum. The transaction terms were not disclosed in the materials reviewed.
Matt Zimmer, global head of investment banking at William Blair, said the acquisition extends the firm's offering across the venture capital, public company, and collegiate communities. Steve Maletzky, head of capital markets, described enterprise value lending as a specialized discipline that finances companies against the value of their assets, often before traditional cash flows exist. Armentum's Hutch Corbett said the combination gives clients access to a broader set of services, including public and private equity capital raising, M&A advisory, secondary advisory, primary fund raising, and equity research.
The acquisition follows rapid growth in private credit and direct lending, as venture-backed and public companies seek flexible, non-dilutive capital for growth in sectors including healthcare innovation, artificial intelligence, software, fintech, and industrial technology. Demand has been especially strong among later-stage technology and biopharmaceutical companies financing clinical trials and commercialization. William Blair has recently expanded its life sciences team with the addition of Michael Allwin as head of Biopharma investment banking, Emanuela Branchetti as managing director of scientific affairs, and Alethia Young in equity research.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.